Grampian Joint Formulary Status for SMC advice published April 2020 to March 2021
Formulary Group minute - 16 February 2021
Formulary Group decisions - March 2021
Drug Safety Update March 2021:
Formulary Group decisions - February 2021
Formulary Group minute - 19 January 2021
Drug Safety Update February 2021:
Formulary Group minute - 15 December 2020
Formulary Group decisions - January 2021
Drug Safety Update January 2021:
Formulary Group minute - 17 November 2020
Formulary Group decisions - December 2020
Drug Safety Update December 2020:
Formulary Group minute - 20 October 2020
Formulary Group decisions - November 2020
Drug Safety Update November 2020:
Formulary Group minute - 15 September 2020
Formulary Group decisions - October 2020
MHRA: Milestone 1 million Yellow Card report for suspected side effects in #MedSafetyWeek
Drug Safety Update October 2020:
MHRA: Warfarin and other blood thinners – reminder on safe use during COVID-19 pandemic
MHRA: Warfarin and other anticoagulants – monitoring of patients during the COVID-19 pandemic
Formulary Group minute - 18 August 2020
Formulary Group decisions - September 2020
Primary Care Prescribing Group - COVID-19 update Vitamin D (All Ages): Advice For Prescribers
Drug Safety Update September 2020:
Formulary Group decisions - August 2020
Drug Safety Update - August 2020
NHS Grampian emollient choices has now been updated:
For more information see - 13.2.1 Emollients
Drug Safety Update July 2020
Formulary Group (Executive Group) decisions - July 2020
Formulary Group (Executive Group) decisions - June 2020
Drug Safety Update June 2020
Formulary Group (Executive Group) decisions - May 2020
Coronavirus (COVID-19) - Antibiotic Management/Antimicrobial Stewardship in the Context of the COVID-19 Pandemic, Version 2
Guidance for repurposing Prescription Only Medicines (PoMs) in Care Homes and Hospices during the COVID-19 pandemic:
Coronavirus (COVID-19) - Guidance For GP Practices And Care Homes Regarding The Supply And Administration Of Palliative Care Medicines During COVID-19, Version 1.1
Drug Safety Update May 2020
MHRA: Patients informed to exchange Emerade 500 micrograms adrenaline pens for a different brand
Grampian Joint Formulary Status for SMC advice published April 2019 to March 2020 [updated to April 2020 decisions]
MHRA: Valproate Pregnancy Prevention Programme: temporary advice for management during coronavirus (COVID-19)
Formulary Group (Executive Group) decisions - April 2020
Coronavirus (COVID-19) - Frequently Asked Questions – Guidance for GP Practices and Care Homes regarding the Supply and Administration of Palliative Care Medicines during COVID-19, Version 1
Drug Safety Update - April 2020
Coronavirus (COVID-19) - Medication use for Acute behavioural disturbance during the COVID-19 Pandemic
Coronavirus (COVID-19) - PGD for the administration of medicines included in the COVID-19 End Of Life Care PGD Formulary
Coronavirus (COVID-19) - Liverpool Drug Interactions Group - Interactions with Experimental COVID-19 Therapies
Coronavirus (COVID-19) - Managing antipsychotic depots or long-acting injections during the COVID-19 Pandemic, Version 1
Coronavirus (COVID-19) - Monitoring lithium during the COVID-19 Pandemic
Coronavirus (COVID-19) - Maintaining clozapine treatment during the COVID-19 outbreak
Coronavirus (COVID-19) - Antibiotic management in frail older people with respiratory infections during the COVID-19 Pandemic, Version 1
Coronavirus (COVID-19) - Guidance for switching warfarin to DOACs for Adults with non-valvular AF and DVT/PE during the COVID-19 Pandemic
Formulary Group minute - 18 February 2020
Formulary Group (Executive Group) decisions - March 2020
New monitoring schedules for DMARDS available. The new schedules are independent of indication, and have been agreed with the specialties (rheumatology/ophthalmology/dermatology/paediatrics) in Secondary care.
Coronavirus (COVID-19) - PGD to allow to Community Pharmacists to pack down paracetamol PoM packs for self-isolating patients who have fever associated with COVID-19 is now available - Covering letter and Patient Group Direction
Drug Safety Update - March 2020
EMA - Suspension of ulipristal acetate (5mg) for uterine fibroids during ongoing EMA review of liver injury risk - March 2020
Formulary Group minute - 21 January 2020
Formulary Group decisions - February 2020
Drug Safety Update - February 2020
Updated guidance regarding the recommended Nexplanon insertion site
Formulary Group minute - 17 December 2019
Formulary Group minute - 19 November 2019
Formulary Group decisions - January 2020
Drug Safety Update - January 2020
Formulary Group decisions - December 2019
Drug Safety Update - December 2019
Formulary Group minute - 17 September 2019
Formulary Group decisions - November 2019
MHRA: Class 2 Medicines recall: Emerade 150, 300 and 500 microgram solution for injection in pre-filled syringe (MDR 57-08/19) - November 2019
Drug Safety Update - November 2019
Drug Safety Update: Prescribing medicines in renal impairment: using the appropriate estimate of renal function to avoid the risk of adverse drug reactions - October 2019
October 2019 Formulary Group Meeting Cancelled
Drug Safety Update - October 2019
NHS Grampian HIV medicines list (October 2019)
Formulary Group minute - 20 August 2019
Formulary Group decisions - September 2019
Drug Safety Update - September 2019
Formulary Group minute - 16 July 2019
Formulary Group decisions - August 2019
Q&A: Can miconazole oral gel be used by patients taking a statin?
Drug Safety Update: Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping - 30 August 2019
Drug Safety Update - August 2019
Formulary Group decisions - July 2019
Formulary Group minute - 18 June 2019
Q&A - Excipients: What are the general considerations for vegan patients?
Drug Safety Update - July 2019
Formulary Group minute - 21 May 2019
Formulary Group decisions - June 2019
Drug Safety Update - June 2019
Grampian Joint Formulary Status for SMC advice published April 2018 to March 2019 (updated May 2019)
Formulary Group minute - 16 April 2019
Formulary Group decisions - May 2019
SDcep Drug Prescribing for Dentistry
SAPG New guidance on antibiotic dosing in obesity
Formulary Group minute - 19 March 2019
Formulary Group decisions - April 2019
Valproate medicines and serious harms in pregnancy: new Annual Risk Acknowledgement Form and clinical guidance from professional bodies to support compliance with the Pregnancy Prevention Programme
Drug Safety Update - April 2019
Formulary Group minute - 19 February 2019
Formulary Group decisions - March 2019
Drug Safety Update - March 2019
Formulary Group decisions - February 2019
Formulary Group minute - 15 January 2019
Gabapentin and pregabalin will become Schedule 3 Controlled Drugs in April 2019 / FAQ document
Drug Safety Update - February 2019
Formulary Group decisions - January 2019
Formulary Group minute - 18 December 2018
Drug Safety Update - January 2019
HIV medicines list updated
Formulary Group minute - 20 November 2018
Drug Safety Update - December 2018
Formulary Group decisions - December 2018
Drug Safety Update - November 2018
Teething gels for babies and children to be sold in pharmacies only
Formulary Group decisions - November 2018
Formulary Group minute - 16 October 2018
Formulary Group decisions - October 2018
Drug Safety Update - October 2018
Formulary Group minute - 18 September 2018
Shortage of Epipen
Formulary Group decisions - September 2018
Drug Safety Update - September 2018
Formulary Group minute - 21 August 2018
Formulary Group decisions - August 2018
Drug Safety Update - August 2018
Formulary Group minute - 17 July 2018
Formulary Group decisions - July 2018
Drug Safety Update - July 2018
Formulary Group minute - 19 June 2018
Formulary Group decisions - June 2018
Drug Safety Update - June 2018
Q&A - Which oral antihistamines are safe to use whilst breastfeeding?
Q&A - Is there a lactose-free antidepressant?
Q&A - Glucosamine – what are the adverse effects?
Impact newsletter - May 2018
Formulary Group minute - 15 May 2018
Formulary Group decisions - May 2018
Drug Safety Update - May 2018
SIGN 151 - Management of stable angina
Q&A - Which medicines require extra care when switching between liquid and tablet/capsule formulations?
Q&A - Gabapentin and pregabalin—are they safe whilst breastfeeding?
Formulary Group minute - 17 April 2018
Formulary Group decisions - April 2018
Drug Safety Update - April 2018
Q&A - Which medicines can be used to treat intermittent allergic rhinitis during pregnancy?
Q&A - Do statins cause alopecia?
Formulary Group minute - 20 March 2018
Formulary Group decisions - March 2018
Drug Safety Update - March 2018
SIGN 155 - Pharmacological management of migraine
Q&A - Oseltamivir or zanamivir – can mothers breastfeed after treatment for influenza?
Q&A - Is there a lactose-free hormone replacement therapy (HRT)?
Formulary Group minute - 20 February 2018
Formulary Group decisions - February 2018
Drug Safety Update - February 2018
Impact newsletter - January 2018
Formulary Group minute - 16 January 2018
Formulary Group decisions - January 2018
Drug Safety Update - January 2018
Formulary Group minute - 19 December 2017
Formulary Group decisions - December 2017
Drug Safety Update - December 2017
SIGN 154 and 116 - Management of diabetes
Q&A - What are the clinically significant drug interactions with cigarette smoking?
Q&A - Can high dose loperamide be used to reduce stoma output?
Impact newsletter - November 2017
Formulary Group minute - 21 November 2017
Formulary Group decisions - November 2017
Drug Safety Update - November 2017
Q&A - Is there an interaction between warfarin and proton pump inhibitors?
Formulary Group minute - 17 October 2017
Formulary Group decisions - October 2017
Drug Safety Update - October 2017
Formulary Group minute - 19 September 2017
Formulary Group decisions - September 2017
Drug Safety Update - September 2017
Impact newsletter - August 2017
Formulary Group minute - 15 August 2017
Formulary Group decisions - August 2017
Drug Safety Update - August 2017
SIGN 150 - Cardiac rehabilitation
SIGN 149 - Risk estimation and the prevention of cardiovascular disease
Impact newsletter - July 2017
Formulary Group minute - 18 July 2017
Formulary Group decisions - July 2017
Drug Safety Update - July 2017
Formulary Group minute - 20 June 2017
Formulary Group decisions - June 2017
Drug Safety Update - June 2017
Q&A - Is there an interaction between bisphosphonates and proton pump inhibitors?
Q&A - Do proton pump inhibitors reduce the clinical efficacy of clopidogrel?
Impact newsletter - May 2017
Drug Safety Update - May 2017
Formulary Group minute - 18 April 2017
Formulary Group decisions - April 2017
Drug Safety Update - April 2017
Formulary Group minute - 21 March 2017
Formulary Group decisions - March 2017
Drug Safety Update - March 2017
Q&A - What are the differences between different brands of mesalazine tablets?
Q&A - Is there an interaction between erythromycin and statins?
Formulary Group minute - 21 February 2017
Formulary Group decisions - February 2017
Drug Safety Update - February 2017
Q&A - What is the optimal prokinetic dose of erythromycin in adults?
SIGN 146 - Cutaneous melanoma
Formulary Group decisions - January 2017
Formulary Group minute - 17 January 2017
Drug Safety Update - January 2017